Table 4.
Subgroup analysis | No. of studies | No. of patients | Pooled HR (95% CI) | Meta regression (p -value) | Heterogeneity | ||
---|---|---|---|---|---|---|---|
Fixed | Random | I2 (%) | p-value | ||||
Region | |||||||
Western | 2 | 358 | 3.885 [2.185–6.907] | 3.885 [2.185–6.907] | 0.027 | 0 | 0.926 |
Eastern | 7 | 1577 | 1.299 [1.071–1.576] | 1.313 [0.973–1.772] | 54.8 | 0.039 | |
Sample size | |||||||
< 200 | 5 | 565 | 1.320 [0.972–1.792] | 1.588 [0.832–3.032] | 0.850 | 75.6 | 0.003 |
≥ 200 | 4 | 1370 | 1.530 [1.209–1.742] | 1.641 [1.092-2.465] | 66.1 | 0.031 | |
Cut-off value | |||||||
< 3.0 | 4 | 830 | 1.445 [1.209–1.742] | 1.660 [1.048–2.629] | 0.697 | 50.2 | 0.110 |
≥ 3.0 | 5 | 1105 | 1.449 [1.144–1.834] | 1.511 [0.874–2.612] | 79.8 | 0.001 | |
NOS score | |||||||
≥ 7 | 5 | 1518 | 1.561 [1.262–1.931] | 1.648 [1.183–2.297] | 56.0 | 0.059 | |
< 7 | 4 | 417 | 1.179 [0.824–1.688] | 1.576 [0.674–3.688] | 0.757 | 80.0 | 0.002 |
NOS Newcastle–Ottawa Quality Assessment Scale